|
Volumn 2, Issue 6, 1993, Pages 503-506
|
Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANABOLIC AGENT;
ANCROD;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CONTRACEPTIVE AGENT;
FIBRIC ACID DERIVATIVE;
FIBRINOGEN;
FIBRINOLYTIC AGENT;
FIBRINOPEPTIDE A;
FISH OIL;
GEMFIBROZIL;
GLYCOSAMINOGLYCAN;
HEPARIN;
ICOSAPENTAENOIC ACID;
NICOTINIC ACID;
PENTOXIFYLLINE;
PLACEBO;
PLASMA PROTEIN;
TICLOPIDINE;
WARFARIN;
ACUTE HEART INFARCTION;
ALCOHOL CONSUMPTION;
ARTICLE;
BIOCHEMISTRY;
BLOOD CLOTTING;
BLOOD VISCOSITY;
CARDIOVASCULAR DISEASE;
CAROTID ARTERY OBSTRUCTION;
CEREBROVASCULAR DISEASE;
CHOLESTEROL INTAKE;
CIGARETTE SMOKING;
CONTROLLED STUDY;
ECHOGRAPHY;
FEMALE;
FIBRINOGEN BLOOD LEVEL;
GLUCOSE INTAKE;
HEMOSTASIS;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
ISCHEMIC HEART DISEASE;
MALE;
ORAL DRUG ADMINISTRATION;
RISK FACTOR;
STROKE;
THROMBOCYTE AGGREGATION;
ANCROD;
ANTICOAGULANTS;
ANTILIPEMIC AGENTS;
CEREBROVASCULAR DISORDERS;
FIBRINOGEN;
HUMAN;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0027491023
PISSN: 10582819
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|